30th January 2024 – (San Francisco) Elon Musk, the visionary entrepreneur behind companies such as Tesla and SpaceX, announced on Monday that his neurotech startup, Neuralink, has successfully implanted its device in a human for the first time. Musk shared the news on X, the social media platform formerly known as Twitter, stating that the patient is “recovering well.” He also mentioned that the initial results indicate promising neuron spike detection.
Neuralink’s groundbreaking first product, aptly named Telepathy, aims to revolutionise the lives of patients suffering from severe paralysis by allowing them to control external technologies using neural signals alone. The innovative brain implant holds the potential to enable individuals to communicate and interact with the world around them in ways previously unimaginable.
In an additional post, Musk highlighted the transformative impact this technology could have by referencing renowned physicist Stephen Hawking. He envisioned a future where individuals like Hawking, who had limited physical abilities due to his battle with motor neuron disease, could communicate at a pace surpassing that of a skilled typist or auctioneer. This ambitious goal exemplifies Neuralink’s mission to enhance the quality of life for individuals facing physical limitations.
Neuralink embarked on its first-in-human clinical trial after receiving approval from the U.S. Food and Drug Administration (FDA) in May of the previous year. The company initiated the recruitment of patients for this groundbreaking trial during the autumn months. The successful implantation marks a significant milestone in the development of Neuralink’s technology, paving the way for potential breakthroughs in restoring communication and control to those who have lost these abilities due to paralysis.